USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

Q: Where does Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine ranks #37,442 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Q: Is Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine.

Q: How is the Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 7 granted patents across 9 technology areas, recorded in grant years 2023–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Shanghai ranks #37,442 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 9 technology areas.

#37,442
of 49,997 US assignees by volume: Top 34%
by Innovation Score (41.0/100): 5.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R37442 · Foreign Corporation #37,442 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #37,442/49,997
PHOTO-FINISH Shandong Huaxia…
CPC-NARROW A61B · 9 areas
INNOV-PAR 41.0/100
CLAIMS-SPARSE 5.3 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2023–2024 · 2y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Shandong Huaxia Shenzhou New Material Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Shanghai’s 41.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (18%) Velocity 20.0 pts (49%) Breadth 10.6 pts (26%) Claim depth 3.2 pts (8%)

Qualcomm Incorporated · highest

85
National Dentex · near

41
Reckitt Benckiser · near

41
Shanghai Ninth… · this assignee

41
Tesseract Ventures · near

41
Xenon Pharmaceuticals · near

41
3D Lighting… · lowest

7

What this shows Shanghai's Innovation Score is 41.0/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Shanghai?

Each dot is one of Shanghai’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Shanghai’s own 5.3 claims/patent is at or below the 7.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Shanghai vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Shanghai's grants concentrate

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine is a focused PatentsView assignee: 9 CPC subclasses with 42.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (5 grants) versus a trough of 2 in 2024. By volume, Shanghai sits between Shandong Huaxia Shenzhou New Material Co., Ltd. and SharpMed, LLC..

Shanghai's three-year grant acceleration

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine shows 7 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Shandong Huaxia S…

7
Shanghai Fudan Mi…

7
Shanghai Huachang…

7
Shanghai Maodouya…

7
Shanghai Pioneer…

7
Shannon Specialty…

7
Shantou Fengma To…

7
Sharpmed

7
Shanghai Ninth Pe… ◀

7

What this shows Shanghai holds 7 patents at rank #37,585, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Shanghai

By rank, the assignees closest to #37,585 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Shanghai's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Shanghai, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Shanghai ranks #4,165 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Tesseract Ventures, LLC 41 National Dentex, LLC 41 Xenon Pharmaceuticals Inc. 41 Reckitt Benckiser LLC 41

Shanghai's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	5	71.4%
2024	2	28.6%

Which technologies does Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine patent most?

A61B - DIAGNOSIS; SURGERY; Identification 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

C07K - Peptides 1

G10L - Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

C12Y - Enzymes 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine's patent record in context - here's where to go next.

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 42.9% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #37,442 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine against Shandong Huaxia Shenzhou New Material Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.